Beyond Meat faces a potential delisting from the Nasdaq Global Select Market after its shares traded below the minimum threshold of $1 for 30 straight business days.

In a SEC filing on Friday (6 March), the loss-making plant-based meat maker said it received a deficiency letter from Nasdaq’s Listing Qualifications Department on 4 March.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The notice does not immediately affect trading, the California-based alternative protein producer said.

Its shares will continue to trade under the BYND ticker for now.

Beyond Meat’s stock slid through $1 late last year and has traded below that level for most of 2026. The shares have slumped almost 76% in the past 12 months and last traded at $0.79.

The warning lands after a bruising period marked by falling sales and volumes, widening losses and balance-sheet strains. The company has not turned a profit since going public through an IPO in 2019.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Investors are awaiting the issuance of Beyond Meat’s results for the final quarter of fiscal 2025 for signs of any turnaround.

Beyond Meat has 180 calendar days to regain Nasdaq listing compliance, giving it until 31 August.

“To regain compliance, the closing bid price of the company’s common stock must be at least $1.00 per share for a minimum of ten consecutive business days before the compliance date,” the filing read.

If Beyond Meat fails to meet the threshold by then, the company may qualify for a second 180-day period.

That would require a transfer to the Nasdaq Capital Market and meeting other continued listing standards, apart from the bid-price rule.

In addition, Beyond Meat would be required to “notify Nasdaq of its intent to cure the deficiency during the second compliance period, by effecting a reverse stock split if necessary”.

Beyond Meat said it will “monitor the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance”, including “initiating a reverse stock split”.

Shareholders already approved flexibility for such a move in November 2025, according to the SEC filing.

At a special meeting, investors backed 30 alternate amendments allowing the board to initiate a reverse split ratio if needed.

Management had already outlined a turnaround “reset”, including cost reductions, margin expansion efforts and unspecified strategic initiatives.

In late 2025, Beyond Meat launched and then completed a debt exchange aimed at eliminating more than $800m in debt, triggering a slide in its shares below $1.

The transaction extended maturities to 2030 but increased interest costs and triggered equity dilution.

In November, the company reported a $77.4m impairment charge tied to long-lived assets and the previously reported wind-down of its China operations.

Beyond Meat also pointed to arbitration-related legal expenses and other non-routine costs.

In January, shareholders filed lawsuits alleging disclosure failings linked to the impairment and related SEC filing delays.